[Delays in the diagnosis and surgical treatment of bronchogenic carcinoma. Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S)]
- PMID: 9611636
[Delays in the diagnosis and surgical treatment of bronchogenic carcinoma. Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S)]
Abstract
The aim of this study was to determine the delay between clinical suspicion and diagnosis of bronchogenic carcinoma, and between diagnosis and performance of therapeutic thoracotomy. The study population included 598 patients undergoing surgery between October 1995 and September 1996 registered in the Bronchogenic Carcinoma Cooperation Group of SEPAR (BCCG-S), and 49 patients from our hospital undergoing surgery during the same period. The mean delay between diagnosis and thoracotomy was 45.15 days (SD 34.7 days) for BCCG-S patients and 53.5 days (SD 22 days) for our hospital patients. In the second group, mean time elapsing between diagnosis suspicion and performance of bronchoscopy was known to be 9.5 days (SD 14.7 days), with the lowest periods recorded for inpatients (3.1 +/- 1.7 days) and for patients who did not require chest x ray guided bronchoscopy (5 +/- 5.8 days). These data are similar to those published for hospitals in other countries. They must be considered long delays and should be shortened.
Similar articles
-
Influence of delays on survival in the surgical treatment of bronchogenic carcinoma.Lung Cancer. 2002 Apr;36(1):59-63. doi: 10.1016/s0169-5002(01)00458-5. Lung Cancer. 2002. PMID: 11891034
-
[The surgery of bronchogenic carcinoma in Spain. A descriptive study. The Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S). Sociedad Española de Neumología y Cirugía Torácica].Arch Bronconeumol. 1995 Jun-Jul;31(6):303-9. Arch Bronconeumol. 1995. PMID: 7627429 Spanish. No abstract available.
-
The Spanish data base for the staging of lung cancer. Experience of the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).Ann Ital Chir. 1999 Nov-Dec;70(6):907-8. Ann Ital Chir. 1999. PMID: 10804671
-
Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy.Minerva Chir. 2010 Dec;65(6):635-54. Minerva Chir. 2010. PMID: 21224798 Review.
-
[Recent advances in bronchogenic carcinoma].Gac Med Mex. 1991 Jan-Feb;127(1):47-63. Gac Med Mex. 1991. PMID: 1959739 Review. Spanish. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical